证券代码：300677 证券简称：英科医疗 公告编号：2025-111 英科医疗科技股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没 有虚假记载、误导性陈述或重大遗漏。 英科医疗科技股份有限公司（以下简称"公司"）于 2024 年 9 月 19 日召开第三届董事会第二十五次会议和第三届监事会第二十三 次会议，审议通过了《关于公司回购股份方案的议案》，同意公司使 用不低于人民币 8,000 万元（含本数）且不超过人民币 12,000 万元 （含本数）的自有资金，以集中竞价交易的方式回购部分公司股份（人 民币普通股（A 股）股票），用于实施员工持股计划及/或股权激励。 回购价格不超过人民币 26.51 元/股（含本数），回购股份的数量和金 额以回购期限届满时实际回购的股份数量和金额为准。回购股份的实 施期限为自公司第三届董事会第二十五次会议审议通过本次回购股 份方案之日起不超过 12 个月。具体内容详见公司分别于 2024 年 9 月 19 日、2024 年 9 月 20 日、2024 年 10 月 31 日、2025 年 6 月 13 日披 露于巨潮资讯网（www ...

Market Overview - On August 1, the medical device sector rose by 0.18% compared to the previous trading day, with Lidman leading the gains [1] - The Shanghai Composite Index closed at 3559.95, down 0.37%, while the Shenzhen Component Index closed at 10991.32, down 0.17% [1] Top Gainers in Medical Device Sector - Lidman (300289) closed at 8.45, up 20.03% with a trading volume of 588,100 shares and a transaction value of 496 million yuan [1] - Rejing Bio (688068) closed at 216.50, up 11.03% with a trading volume of 44,000 shares and a transaction value of 948 million yuan [1] - Guanwu Bio (300238) closed at 19.00, up 9.20% with a trading volume of 470,900 shares and a transaction value of 878 million yuan [1] - Yingke Medical (300677) closed at 37.28, up 8.53% with a trading volume of 447,500 shares and a transaction value of 1.643 billion yuan [1] - Other notable gainers include Zhonghong Medical (300981), Sainuo Medical (688108), and Kemei Diagnosis (688468) with respective increases of 8.05%, 6.70%, and 6.66% [1] Top Losers in Medical Device Sector - Huakang Clean (301235) closed at 33.10, down 5.97% with a trading volume of 158,600 shares [2] - Kangtai Medical (300869) closed at 19.80, down 4.35% with a trading volume of 284,800 shares and a transaction value of 571 million yuan [2] - Other significant decliners include XD Chunli Medical (688236), Haooubo (688656), and Huqiang Technology (688151) with respective declines of 3.67%, 3.13%, and 3.10% [2] Capital Flow in Medical Device Sector - On the same day, the medical device sector saw a net inflow of 40.108 million yuan from institutional investors, while retail investors experienced a net outflow of 93.3185 million yuan [2][3] - Notable net inflows from institutional investors included Lepu Medical (300003) with 57.2395 million yuan and Guanwu Bio (300238) with 57.033 million yuan [3] - Conversely, significant net outflows from retail investors were observed in Lepu Medical (-82.3375 million yuan) and Guanwu Bio (-11.5 million yuan) [3]

（文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：现在出口至美国的税率是多少？越南公司投产后的出 口美国税率是多少？马来西亚征收25%的税率对公司出口美国是不是有正面影响？ 英科医疗（300677.SZ）8月1日在投资者互动平台表示，目前公司出口美国的手套产品税率按美国海关 最新政策执行；越南基地投产后，其出口美国的税率将根据当地贸易政策确定，预计较国内出口更具优 势。马来西亚相关税率政策对公司出口美国暂无直接正面影响，公司主要通过自有海外产能布局应对关 税波动。 ...

Group 1 - The core viewpoint is that the healthcare equipment and services sector is experiencing positive momentum due to recent government initiatives aimed at supporting the high-quality development of innovative drugs and medical devices [1][2] - The CSI All Share Healthcare Equipment and Services Index (H30178) saw a significant increase, with notable stock performances including Diligent Medical (up 20.03%), Hotgen Biotech (up 9.14%), and others [1] - The National Medical Insurance Administration has initiated the 11th batch of drug procurement, focusing on optimizing procurement rules to ensure clinical stability, quality assurance, and prevent price collusion [1] Group 2 - CITIC Securities anticipates that for categories already included in national or provincial procurement, there may be price increases upon renewal, while categories not yet included may see moderate price reductions or no procurement at all [2] - The trend of optimizing procurement processes is expected to enhance market sentiment, leading to a valuation recovery for companies within the sector as they approach performance turning points in the second half of the year [2] - The CCB CSI All Share Healthcare Equipment and Services ETF (159891) closely tracks the CSI All Share Healthcare Equipment and Services Index, reflecting the overall performance of listed companies in the healthcare theme [2]

Group 1 - The core strategy of the company is to consolidate its advantages in disposable protective products and rehabilitation equipment, with no current plans to invest in high-tech medical industries such as brain-computer interfaces or gene sequencing [1] - The company will focus on upgrading its core business technology and market expansion, and will fulfill its information disclosure obligations if there are any new business plans in the future [1]

来源：金融界 最近三个交易日，29日-31日，英科医疗分别获融资买入0.53亿元、1.05亿元、1.28亿元。 融券方面，当日融券卖出0.38万股，净卖出0.11万股。 7月31日，沪深两融数据显示，英科医疗获融资买入额1.28亿元，居两市第313位，当日融资偿还额1.12 亿元，净买入1650.96万元。 ...

Core Viewpoint - The company has experienced simultaneous increases in cash and debt, which are attributed to strategic decisions aimed at balancing liquidity and development needs [1] Group 1: Cash Increase - The increase in cash is primarily due to operational accumulation and strategic reserves [1] - Cash is being allocated for overseas capacity construction, raw material procurement, and to address industry cycle fluctuations [1] Group 2: Debt Increase - The rise in debt is mainly from short-term borrowings [1] - These borrowings are intended to optimize the capital structure, support overseas projects, and fund daily operations [1] - The configuration of cash and debt is aligned with the company's operational planning [1]

来源：金融界 金融界8月1日消息，有投资者在互动平台向英科医疗提问：亲爱的董秘你好，请问公司的一次性手套是 否有销售到四川和西藏呢？谢谢您的回答。 公司回答表示：尊敬的投资者您好，公司一次性手套产品已覆盖全国各省市，包括四川和西藏地区，通 过经销商及直营渠道满足当地医疗、卫生等领域的需求。感谢您的关注！ ...

Core Viewpoint - The company is focused on consolidating its core business in disposable protective products and rehabilitation equipment, with no current plans to invest in high-tech medical industries such as brain-computer interfaces or gene sequencing [1] Group 1 - The company responded to an investor inquiry regarding potential investments in high-tech medical sectors, stating that its current strategic focus is on strengthening its main business [1] - The company emphasized that it will concentrate on technology upgrades and market expansion within its core business [1] - The company assured that any new business plans will be disclosed in a timely manner [1]

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 投资者提问：目前美元处于贬值周期，美联储预期最早在三季度降息，请问贵司美元资产如何保值增 值，是否存在贬值风险 证券之星消息，英科医疗(300677)07月31日在投资者关系平台上答复投资者关心的问题。 英科医疗回复：尊敬的投资者您好，公司通过外汇远期合约等工具对冲美元贬值风险，同时优化美元资 产配置（如活期存款、短期理财），在保障流动性的同时降低贬值风险。感谢您的关注！ ...